Ethyl biscoumacetate

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Ethyl biscoumacetate
Systematic (IUPAC) name
ethyl 2,2-bis(4-hydroxy-2- oxo-2H-chromen-3-yl)acetate
Identifiers
CAS number	548-00-5
ATC code	B01AA08
PubChem	11047
Chemical data
Formula	C22H16O8
Mol. mass	408.358 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

WikiDoc Resources for Ethyl biscoumacetate
Articles
Most recent articles on Ethyl biscoumacetate Most cited articles on Ethyl biscoumacetate Review articles on Ethyl biscoumacetate Articles on Ethyl biscoumacetate in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ethyl biscoumacetate Images of Ethyl biscoumacetate Photos of Ethyl biscoumacetate Podcasts & MP3s on Ethyl biscoumacetate Videos on Ethyl biscoumacetate
Evidence Based Medicine
Cochrane Collaboration on Ethyl biscoumacetate Bandolier on Ethyl biscoumacetate TRIP on Ethyl biscoumacetate
Clinical Trials
Ongoing Trials on Ethyl biscoumacetate at Clinical Trials.gov Trial results on Ethyl biscoumacetate Clinical Trials on Ethyl biscoumacetate at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ethyl biscoumacetate NICE Guidance on Ethyl biscoumacetate NHS PRODIGY Guidance FDA on Ethyl biscoumacetate CDC on Ethyl biscoumacetate
Books
Books on Ethyl biscoumacetate
News
Ethyl biscoumacetate in the news Be alerted to news on Ethyl biscoumacetate News trends on Ethyl biscoumacetate
Commentary
Blogs on Ethyl biscoumacetate
Definitions
Definitions of Ethyl biscoumacetate
Patient Resources / Community
Patient resources on Ethyl biscoumacetate Discussion groups on Ethyl biscoumacetate Patient Handouts on Ethyl biscoumacetate Directions to Hospitals Treating Ethyl biscoumacetate Risk calculators and risk factors for Ethyl biscoumacetate
Healthcare Provider Resources
Symptoms of Ethyl biscoumacetate Causes & Risk Factors for Ethyl biscoumacetate Diagnostic studies for Ethyl biscoumacetate Treatment of Ethyl biscoumacetate
Continuing Medical Education (CME)
CME Programs on Ethyl biscoumacetate
International
Ethyl biscoumacetate en Espanol Ethyl biscoumacetate en Francais
Businness
Ethyl biscoumacetate in the Marketplace Patents on Ethyl biscoumacetate
Experimental / Informatics
List of terms related to Ethyl biscoumacetate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Ethyl biscoumacetate is a vitamin K antagonist.

References

v • d • e Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)
Vitamin K antagonists	Acenocoumarol • Clorindione • Coumatetralyl • Dicumarol (Dicoumarol) • Diphenadione • Ethyl biscoumacetate • Phenprocoumon • Phenindione • Tioclomarol • Warfarin
Heparin group	Antithrombin III • Danaparoid • Heparin • Sulodexide • low molecular weight heparin (Bemiparin, Dalteparin, Enoxaparin, Nadroparin, Parnaparin, Reviparin, Tinzaparin)
Glycoprotein IIb/IIIa inhibitors	Abciximab • Eptifibatide • Tirofiban
Other platelet aggregation inhibitors	Acetylsalicylic acid/Aspirin • Aloxiprin • Ditazole • Carbasalate calcium • Cloricromen • Dipyridamole • Indobufen • Picotamide • Triflusal • ADP receptor inhibitors (Clopidogrel, Ticlopidine, Prasugrel) • prostaglandin analogue (Beraprost, Prostacyclin, Iloprost, Treprostinil)
Enzymes	plasminogen activators (Alteplase/Reteplase/Tenecteplase, Streptokinase, Urokinase/Saruplase, Anistreplase) • other serine endopeptidases (Ancrod, Drotrecogin alfa/Protein C, Fibrinolysin) • Brinase
Direct thrombin inhibitors	Argatroban • Bivalirudin • Dabigatran • Desirudin • Hirudin • Lepirudin • Melagatran • Ximelagatran
Other antithrombotics	Apixaban • Defibrotide • Dermatan sulfate • Fondaparinux • Idraparinux • Otamixaban • Rivaroxaban
Non-medicinal	Citrate • EDTA • Oxalate

WikiDoc Help Menu Quick Start.. Get Started Here! How to Login How to Search Pages How to Start a New Page How to Edit a Page Cheat Sheet Editing basics Learning Basic Formatting How to make Links in WikiDoc & to External Sites How to Make Lists How to Ignoring Formatting Adding References or Footnotes to Articles Tracking Changes You Have Made How to Put an Article Into a Category When Multiple Topics Should Go To The Same Page (MI, Acute MI, AMI) Using Redirection Advanced editing How to Make Tables How to Insert Images and Other Media How to Add Video Help:How to Make Columns Web Colors How To Make Templates How to Move Pages Inserting Dynamic Dates and Times Inserting WikiDoc Statistics Editing the Table of Contents Communicating your edits Let others know what you changed: The importance of Edit Summaries Minor Edits Edit Conflicts Help Videos You Can Watch Getting Started Video

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .